top of page

VRx@Home Pilot Study

cropped-CABHI_logo_v10_FNL-LOGO_outlines
AGEWELL Logo .png
circle of care logo.png
Acclaim-Health-logo.png
CIHR Logo.png
CCNA Logo.png

We are designing and rigorously evaluating the first Virtual Reality-therapy program for people with dementia (PwD) living at home, administered by their informal caregivers (family/friends). Virtual Reality (VR) presents a unique opportunity to transport people to a world outside of their confined spaces, into calming and stimulating settings (lush forest, peaceful beach, cheerful playground). Virtual Reality-therapy is a non-pharmacological approach that uses VR "experiences'' to stimulate brain function, improve psychological health, engage, and relax. It has potential to reduce symptoms of dementia such as apathy, depression, loneliness, sundowning, and the use of sedating medications with known negative side-effects.

​

Caregivers of PwD are more likely to feel worried, tired, overwhelmed, and depressed than non-PwD caregivers. Symptoms of dementia and caregiver stress often result in early institutionalization of PwD; management of challenging symptoms may help PwD remain in their homes for longer while improving their, and their caregivers', Quality of Life (QoL). Addressing the wellbeing of caregivers is an often overlooked, yet integral part of interventions for PwD. It ensures intervention feasibility but also has a distinct impact on our system, reducing healthcare needs of caregivers and allowing them to continue contributing as caregivers.

​

In this pilot study we trained and assisted  caregivers to conduct Virtual Reality-therapy with their loved-ones at home using two devices: a head-mounted display and a tablet. This pilot study assessed: (1) the acceptability of the VR devices (2) feasibility of the study methods, (3) the impact of VR-therapy on PwD and caregiver outcomes. 

 

Our results suggest that both immersive VR and tablet-based technologies are safe and feasible when delivered at home by family caregivers, with promise to impact mood, quality of life, and wellbeing. We found that the tablet lent itself better to a joint experience and was easier to use, more comfortable, and more relaxing. On the other hand, VR was described as a more powerful experience and “more alive” due to its immersive qualities. 

​

ClinicalTrials ID: NCT04988360 (Full Study: NCT06568211)

​

​Publications

Our team having too much fun
IMG_5726 (1).jpg
IMG_2198.heic
IMG_3641.JPG
IMG_3273.jpg
IMG_2151.heic
IMG_2339.heic
bottom of page